Table 2 SARS-CoV-2 detection in testicular parenchyma
| Â | Genetic evaluations | Protein evaluations | Infection of VERO cells | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Patients | E gene (RD) (CT) | RNP ctrl (CT) | N1 gene (SP) (CT) | β-actin ctrl (CT) | LSPR-nanosensor N shift (nm) | LSPR-nanosensor S shift (nm) | IF Spike (−/+) | 1st day- N1 gene (CT) | 2nd day- N1 gene (CT) | RNP ctrl (CT) | + RNA (CT) | − RNA (CT) | IF Spike (−/+) |
CTRL #1 | - | 20 | - | 18.55 | 0 (−) | 0 (−) | - | - | - | 20 | - | - | - |
CV-19 #1 | - | 23 | 32.78 (+) | 24.59 | 31.5 (+) | 51 (+) | + | 34 (+) | 33 (+) | 29 | 29 (+) | 28 (+) | + |
CV-19 #2 | - | 27 | 36.99 (+) | 18.50 | 13.2 (+) | 18.9 (+) | + | 34 (+) | 34 (+) | 27 | 32 (+) | 33 (+) | - |
CV-19 #3 | - | 22 | 36.34 (+) | 6.36 | 1.2 (−) | 17.5 (+) | + | 34 (+) | 31 (+) | 30 | 26 (+) | 25 (+) | + |
CV-19 #4 | - | 20 | 35.96 (+) | 19.25 | 11.2 (+) | 17 (+) | + | 34 (+) | 32 (+) | 29 | 29 (+) | 28 (+) | + |
CV-19 #5 | - | 20 | 36.14 (+) | 20.03 | 9.9 (+) | 20.9 (+) | + | 32 (+) | 27 (+) | 32 | 23 (+) | 25 (+) | + |
CV-19 #6 | - | 21 | 36.22 (+) | 10.30 | 13.2 (+) | 15 (+) | + | 34 (+) | 32 (+) | 29 | 27 (+) | 27 (+) | - |
CV-19 #7 | - | 20 | 35.37 (+) | 17.67 | 4.5 (−) | 12.4 (+) | + | 34 (+) | 32 (+) | 25 | - | - | + |
CV-19 #8 | 38 (+) | 20 | 35.95 (+) | 19.34 | 17.5 (+) | 17 (+) | + | 34 (+) | 34 (+) | 26 | - | - | + |
CV-19 #9 | - | 21 | - | 19.81 | 12.9 (+) | 17.5 (+) | + | 35 (+) | 34 (+) | 27 | 32 (+) | 35 (+) | - |
CV-19 #10 | - | 23 | 34.03 (+) | 20.71 | 7.2 (+) | 13.6 (+) | + | 34 (+) | 32 (+) | 30 | - | - | - |
CV-19 #11 | - | 23 | 35.65 (+) | 16.27 | 8.7 (+) | 16.5 (+) | + | 34 (+) | 33 (+) | 30 | 29 (+) | 33 (+) | - |